DE69633852D1 - Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden - Google Patents

Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden

Info

Publication number
DE69633852D1
DE69633852D1 DE69633852T DE69633852T DE69633852D1 DE 69633852 D1 DE69633852 D1 DE 69633852D1 DE 69633852 T DE69633852 T DE 69633852T DE 69633852 T DE69633852 T DE 69633852T DE 69633852 D1 DE69633852 D1 DE 69633852D1
Authority
DE
Germany
Prior art keywords
oligonucleotides
vinyl alcohol
vinylamine
administration
cationic copolymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69633852T
Other languages
English (en)
Other versions
DE69633852T2 (de
Inventor
Merrill S Goldenberg
Alice C Beekman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE69633852D1 publication Critical patent/DE69633852D1/de
Application granted granted Critical
Publication of DE69633852T2 publication Critical patent/DE69633852T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DE69633852T 1995-01-25 1996-01-11 Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden Expired - Fee Related DE69633852T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US378301 1995-01-25
US08/378,301 US5629184A (en) 1995-01-25 1995-01-25 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
PCT/US1996/000354 WO1996022792A1 (en) 1995-01-25 1996-01-11 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides

Publications (2)

Publication Number Publication Date
DE69633852D1 true DE69633852D1 (de) 2004-12-23
DE69633852T2 DE69633852T2 (de) 2005-11-03

Family

ID=23492568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633852T Expired - Fee Related DE69633852T2 (de) 1995-01-25 1996-01-11 Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden

Country Status (16)

Country Link
US (1) US5629184A (de)
EP (1) EP0806966B1 (de)
JP (1) JPH11503407A (de)
AT (1) ATE282433T1 (de)
AU (1) AU701543B2 (de)
BR (1) BR9606783A (de)
CA (1) CA2210875C (de)
DE (1) DE69633852T2 (de)
DK (1) DK0806966T3 (de)
ES (1) ES2233960T3 (de)
IL (1) IL116887A0 (de)
MX (1) MX9705536A (de)
PT (1) PT806966E (de)
SI (1) SI0806966T1 (de)
WO (1) WO1996022792A1 (de)
ZA (1) ZA96401B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US8217015B2 (en) * 2003-04-04 2012-07-10 Arrowhead Madison Inc. Endosomolytic polymers
US20010007771A1 (en) * 1996-05-29 2001-07-12 Sean M. Sullivan Cationic polymers and lipids for the delivery of nucleic acids
US6656508B2 (en) 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
FR2766195A1 (fr) * 1997-07-21 1999-01-22 Transgene Sa Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique
WO1999042091A2 (en) * 1998-02-19 1999-08-26 Massachusetts Institute Of Technology Use of polycations as endosomolytic agents
EP0987029B1 (de) * 1998-08-28 2003-01-22 Transgene S.A. Verwendung eines kationischen Polymer zur Herstellung von Nukleinsäure-Komplexe und verwandte Zusammensetzungen
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
KR100482774B1 (ko) * 2002-09-05 2005-04-14 주식회사 마이진 폴리비닐이미다졸계 화합물을 포함하는 유전자 전달체
US20050025741A1 (en) 2003-05-15 2005-02-03 Lau Aldrich N.K. Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis
CA2791853C (en) 2010-02-12 2018-03-06 Rhodia Operations Rheology modifier compositions and methods of use
FI20115664A0 (fi) * 2011-06-23 2011-06-23 Kemira Oyj Polymeerituote ja sen käyttö dispergointiaineena
ES2907486T3 (es) 2015-09-24 2022-04-25 Univ North Carolina Chapel Hill Métodos y composiciones para reducir metástasis
US11254964B1 (en) * 2016-03-15 2022-02-22 Fresenius Kabi Deutschland Gmbh Cell culture methods for increased cell viability
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE751299A (en) * 1970-06-01 1970-11-16 Kakenyaku Kako Kk Dna polyamine compositions for treating - lesions caused by radiation
US4713236A (en) * 1981-12-07 1987-12-15 Morton Thiokol, Inc. Polymeric amine conditioning additives for hair care products
US5194492A (en) * 1988-04-15 1993-03-16 Air Products And Chemicals, Inc. Two-phase process for preparing poly(vinyl alcohol)-co-poly(vinylamine)
US5300566A (en) * 1988-04-15 1994-04-05 Air Products And Chemicals, Inc. Method for preparing poly(vinyl alcohol)-co-poly(vinylamine) via a two-phase process
EP0429842B1 (de) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
US5281307A (en) * 1993-01-13 1994-01-25 Air Products And Chemicals, Inc. Crosslinked vinyl alcohol/vinylamine copolymers for dry end paper addition
WO1994018834A1 (en) * 1993-02-16 1994-09-01 Virginia Tech Intellectual Properties, Inc. Polyelectrolyte dna conjugation and genetic transformation of an animal
US5387641A (en) * 1993-05-25 1995-02-07 Yeung; Dominic W. K. Aqueous polymer emulsions useful as wallcovering prepaste adhesives

Also Published As

Publication number Publication date
ATE282433T1 (de) 2004-12-15
JPH11503407A (ja) 1999-03-26
WO1996022792A1 (en) 1996-08-01
IL116887A0 (en) 1996-05-14
PT806966E (pt) 2005-03-31
BR9606783A (pt) 1997-12-30
CA2210875A1 (en) 1996-08-01
ZA96401B (en) 1996-08-14
ES2233960T3 (es) 2005-06-16
SI0806966T1 (en) 2005-06-30
DK0806966T3 (da) 2005-01-03
CA2210875C (en) 2001-05-01
AU4655496A (en) 1996-08-14
EP0806966B1 (de) 2004-11-17
AU701543B2 (en) 1999-01-28
US5629184A (en) 1997-05-13
MX9705536A (es) 1997-10-31
EP0806966A1 (de) 1997-11-19
DE69633852T2 (de) 2005-11-03

Similar Documents

Publication Publication Date Title
ATE282433T1 (de) Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
ATE264598T1 (de) Methode und vorrichtung zur dynamischen gruppierung von kommunikationseinheiten in einem kommunikationssystem
EP1336600A3 (de) Dimer-selektive rxr Modulatoren und Verfahren zu ihrer Verwendung
CA2312202A1 (fr) Composition cosmetique capillaire sous forme d'emulsion eau-dans-silicone comprenant au moins un polymere fixant
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
MX9707021A (es) Receptor de il-7.
FR2755608B1 (fr) Composition cosmetique comprenant un polymere anionique ou non ionique et une silicone carboxylique
JP2001506668A5 (de)
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
TR199700720A3 (tr) Yüksek vinil içerige sahip hidrojenlenmis stiren-butadien-stiren blok kopolimerler ihtiva eden petrol jeli formülasyonlari.
SE9702385D0 (sv) Method and device in data network
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DK0633763T3 (da) Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug
DE69510162D1 (de) Hydrierte Polybutadien-Blockcopolymer enthaltende Polymermischungen
FR2776188B1 (fr) Oleamide de glycylglycine en dermo-cosmetologie
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
IL149810A0 (en) Method of enhancing immune responses to herpes simplex virus vaccine
ES2172682T3 (es) Preparaciones desodorantes con contenido en quitosano, clorohidrato de aluminio e inhibidores de esterasa.
UA48245C2 (uk) ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ
BR9609114A (pt) Composição inseticida de terra diatomácea
WO1999012945A3 (en) Hydrophobic glycosylamine derivatives, compositions, and methods for use
ES2153594T3 (es) Agente de recubrimiento termoendurecible y su utilizacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee